Published in J Exp Med on November 06, 2000
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 4.54
Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 4.46
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 2.93
The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev (2010) 2.90
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A (2002) 2.20
Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal (2010) 2.04
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol (2007) 2.00
CRP after 2004. Mol Immunol (2004) 1.91
The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology (2004) 1.69
Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol (2010) 1.68
Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A (2006) 1.63
I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med (2002) 1.63
IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol (2009) 1.62
Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol (2008) 1.52
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med (2002) 1.51
Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am J Respir Crit Care Med (2009) 1.45
Innate and adaptive immune response to apoptotic cells. J Autoimmun (2007) 1.42
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. Arthritis Res Ther (2004) 1.38
Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med (2005) 1.38
Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol (2007) 1.36
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology (2005) 1.28
Pentraxins: structure, function, and role in inflammation. ISRN Inflamm (2013) 1.23
Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol (2005) 1.23
The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta (2012) 1.20
Pattern recognition by pentraxins. Adv Exp Med Biol (2009) 1.19
The C-terminus of complement factor H is essential for host cell protection. Mol Immunol (2007) 1.14
Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol (2012) 1.14
Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett (2004) 1.11
Discrimination between host and pathogens by the complement system. Vaccine (2008) 1.11
Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII [corrected]. J Immunol (2009) 1.09
Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Clin Exp Immunol (2004) 1.08
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis (2005) 1.08
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment. Rheumatol Int (2005) 1.06
Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum Immunol (2007) 1.03
Targeted and restricted complement activation on acrosome-reacted spermatozoa. J Clin Invest (2005) 1.02
New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02
Complement-dependent modulation of antitumor immunity following radiation therapy. Cell Rep (2014) 1.01
Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem (2004) 1.00
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther (2003) 1.00
Factor h: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules (2012) 0.99
CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol (2011) 0.95
Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol (2011) 0.94
Specific binding of an antigen-antibody complex to apoptotic human neutrophils. Am J Pathol (2003) 0.94
Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem J (2002) 0.94
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int (2004) 0.93
Pentraxins and Fc receptors. Immunol Rev (2012) 0.92
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm (2013) 0.92
Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction. Ann Rheum Dis (2004) 0.90
NETs: the missing link between cell death and systemic autoimmune diseases? Front Immunol (2013) 0.89
Milk fat globule EGF factor 8 attenuates sepsis-induced apoptosis and organ injury in alcohol-intoxicated rats. Alcohol Clin Exp Res (2010) 0.88
Recognition functions of pentameric C-reactive protein in cardiovascular disease. Mediators Inflamm (2014) 0.86
Human pentraxin 3 binds to the complement regulator c4b-binding protein. PLoS One (2011) 0.86
Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors. Curr Opin Organ Transplant (2011) 0.86
Rat C-reactive protein activates the autologous complement system. Immunology (2003) 0.85
Innate sensing of oxidation-specific epitopes in health and disease. Nat Rev Immunol (2016) 0.84
C-reactive protein does not opsonize early apoptotic human neutrophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophages. J Inflamm (Lond) (2005) 0.84
Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation (2009) 0.84
The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83
Neointimal formation is reduced after arterial injury in human crp transgenic mice. Atherosclerosis (2008) 0.83
Heat-shock protein 60 translocates to the surface of apoptotic cells and differentiated megakaryocytes and stimulates phagocytosis. Cell Mol Life Sci (2010) 0.83
Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. J Rheumatol (2008) 0.83
Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiol Biomarkers Prev (2010) 0.82
C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes. Arthritis Rheum (2013) 0.82
C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis. J Immunol (2015) 0.81
Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int (2013) 0.81
Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. Am J Physiol Renal Physiol (2012) 0.81
Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism. Mol Vis (2012) 0.81
C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP. Anal Bioanal Chem (2011) 0.81
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J Hepatol (2016) 0.80
Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest (2010) 0.80
The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophosphatidylcholine. J Inflamm (Lond) (2012) 0.80
Membrane curvature recognition by C-reactive protein using lipoprotein mimics. Soft Matter (2012) 0.80
Protection of host cells by complement regulators. Immunol Rev (2016) 0.79
Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide. Glycoconj J (2006) 0.79
Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice. Immunology (2004) 0.79
Complement factor H: using atomic resolution structure to illuminate disease mechanisms. Adv Exp Med Biol (2008) 0.79
Current understanding of the mechanisms for clearance of apoptotic cells-a fine balance. J Cell Death (2013) 0.78
Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels (2009) 0.78
SLE-associated risk factors affect DC function. Immunol Rev (2016) 0.78
Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study. Medicine (Baltimore) (2016) 0.78
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study. Arthritis Res Ther (2011) 0.78
Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity. Clin Immunol (2016) 0.78
Association of Metabolites with Obesity and Type 2 Diabetes Based on FTO Genotype. PLoS One (2016) 0.78
Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis. Mediators Inflamm (2009) 0.78
Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk. PLoS One (2014) 0.78
Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus. J Immunol (2016) 0.77
Bilirubin levels in patients with systemic lupus erythematosus: increased or decreased? Rheumatol Int (2011) 0.77
Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis. Inflammation (2016) 0.76
The Complement System and Antibody-Mediated Transplant Rejection. J Immunol (2015) 0.76
Neutrophil responses to CRP are not dependent on polymorphism of human FcgammaRIIA (R131H). Clin Exp Immunol (2004) 0.76
Protective molecules and their cognate antibodies: new players in autoimmunity. Auto Immun Highlights (2010) 0.75
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration. Eye (Lond) (2016) 0.75
Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndrome. Intractable Rare Dis Res (2016) 0.75
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun (2017) 0.75
Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell Death Dis (2016) 0.75
An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. Exp Mol Med (2017) 0.75
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS. J Exp Med (1930) 10.97
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Natural adjuvants: endogenous activators of dendritic cells. Nat Med (1999) 7.10
Immunosuppressive effects of apoptotic cells. Nature (1997) 7.03
The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science (1998) 4.92
Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med (1983) 3.96
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med (1995) 3.48
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today (1994) 3.13
Complement deficiency and disease. Immunol Today (1991) 2.77
C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol (1997) 2.69
Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med (1998) 2.69
The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure (1999) 2.64
Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions. J Exp Med (1961) 2.62
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J (1989) 2.54
Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J Exp Med (1974) 2.47
Apoptosis in rheumatoid arthritis synovium. J Clin Invest (1995) 2.39
Lupus autoantibodies target ribosomal P proteins. J Exp Med (1985) 2.28
C-reactive protein and the acute phase response. Adv Intern Med (1982) 2.20
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med (1999) 2.17
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J Exp Med (1984) 1.85
Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum (1995) 1.85
The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med (1999) 1.84
Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) (1981) 1.83
Regulation of complement activation by C-reactive protein. Immunopharmacology (1999) 1.78
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature (1979) 1.75
Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J Biol Chem (1984) 1.73
Regulation of the complement membrane attack pathway. Crit Rev Immunol (1999) 1.66
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol (1989) 1.66
Apoptosis: the importance of being eaten. Cell Death Differ (1998) 1.65
Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol (1996) 1.64
C1q and systemic lupus erythematosus. Immunobiology (1998) 1.63
Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J Exp Med (1985) 1.60
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest (1999) 1.58
A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today (1997) 1.42
C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest (2000) 1.42
CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol (2000) 1.32
A novel flow cytometric method for quantifying phagocytosis of apoptotic cells. Cytometry (1997) 1.28
Integrins as promiscuous signal transduction devices. Immunol Today (1996) 1.27
C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res (1997) 1.18
The acute-phase response in (NZB X NZW)F1 and MRL/l MICE. J Exp Med (1982) 1.17
Epitope mapping of recombinant HeLa SmB and B' peptides obtained by the polymerase chain reaction. J Immunol (1990) 1.15
Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol (1991) 1.08
The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol Biol Rep (1996) 1.00
Factor H. Curr Top Microbiol Immunol (1990) 0.94
Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. J Immunol (1981) 0.93
Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem (2000) 0.93
Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J Immunol (1986) 0.92
The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis. Coron Artery Dis (1998) 0.87
Genome cross-referencing and XREFdb: implications for the identification and analysis of genes mutated in human disease. Nat Genet (1997) 10.14
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med (1995) 8.51
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell (1995) 6.43
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science (1990) 5.35
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med (1997) 4.10
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Imaging membrane protein helical wheels. J Magn Reson (2000) 3.80
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
"Fluorescent timer": protein that changes color with time. Science (2000) 3.42
Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol (1995) 3.41
Structural basis of the redox switch in the OxyR transcription factor. Cell (2001) 3.32
Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32
Structure of the transmembrane region of the M2 protein H(+) channel. Protein Sci (2001) 3.31
Identification of sequences in a yeast histone promoter involved in periodic transcription. Cell (1986) 3.22
In vivo and in vitro formation of 2,3-dihydroxybenzoylserine by Escherichia coli K12. Biochem Biophys Res Commun (1966) 3.21
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Enzymatic reduction of protein-bound methionine sulfoxide. Proc Natl Acad Sci U S A (1981) 3.09
Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 3.01
Weighted-ensemble Brownian dynamics simulations for protein association reactions. Biophys J (1996) 2.87
Predicting protein diffusion coefficients. Proc Natl Acad Sci U S A (1993) 2.87
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A (1991) 2.81
Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med (1996) 2.78
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res (1997) 2.72
Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med (1998) 2.69
Programmable matter by folding. Proc Natl Acad Sci U S A (2010) 2.65
Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activation sequence but does not require TATA sequences. Mol Cell Biol (1986) 2.63
Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res (2000) 2.62
AN APPROXIMATE CELL MODEL FOR LIQUID HYDROGEN, I. Proc Natl Acad Sci U S A (1962) 2.59
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J (2001) 2.55
Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54
Regulation of 2,3-dihydroxybenzoylserine synthetase by iron. J Biol Chem (1968) 2.52
Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics (1999) 2.50
Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med (1987) 2.47
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood (2000) 2.42
Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res (1998) 2.38
Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc Natl Acad Sci U S A (1996) 2.35
DNA looping generated by DNA bending protein IHF and the two domains of lambda integrase. Science (1989) 2.34
Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev (2001) 2.33
Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substrates. Curr Biol (1997) 2.32
Lupus autoantibodies target ribosomal P proteins. J Exp Med (1985) 2.28
PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem (2000) 2.26
Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med (1997) 2.24
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19
Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1986) 2.18
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16
Modulation of potassium channel function by methionine oxidation and reduction. Proc Natl Acad Sci U S A (1997) 2.16
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Hydrodynamic steering effects in protein association. Proc Natl Acad Sci U S A (1994) 2.09
Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol (2001) 2.07
Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A (1996) 2.05
Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem (1995) 2.05
Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum (1995) 2.03
Cinnamon zeylanicum bark extract and powder mediated green synthesis of nano-crystalline silver particles and its bactericidal activity. Colloids Surf B Biointerfaces (2009) 2.01
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Protein methylation. Science (1971) 1.95
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther (1999) 1.94
Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc Natl Acad Sci U S A (2001) 1.93
Reduction of N-acetyl methionine sulfoxide: a simple assay for peptide methionine sulfoxide reductase. Anal Biochem (1982) 1.88
The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther (2007) 1.85
Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.84
Zuotin, a ribosome-associated DnaJ molecular chaperone. EMBO J (1998) 1.84
Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology (2001) 1.84
Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci U S A (1996) 1.84
The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harb Symp Quant Biol (1998) 1.82
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Enzymatic reduction of oxidized alpha-1-proteinase inhibitor restores biological activity. Proc Natl Acad Sci U S A (1981) 1.78
Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol (2007) 1.77
Biochemistry and physiological role of methionine sulfoxide residues in proteins. Arch Biochem Biophys (1983) 1.77
Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proc Natl Acad Sci U S A (2000) 1.76
The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci U S A (1993) 1.76
Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment. Circ Res (2001) 1.76
In vitro effect of the Escherichia coli heat shock regulatory protein on expression of heat shock genes. J Bacteriol (1986) 1.75
Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein. Cell (1995) 1.75
Protein methylase I. Purification and properties of the enzyme. J Biol Chem (1968) 1.75
3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced Bolus-Chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol (2008) 1.74
Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol (2001) 1.74
Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev (2006) 1.74
Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73
Longitudinal versus cross-sectional evaluations of leukocyte telomere length dynamics: age-dependent telomere shortening is the rule. J Gerontol A Biol Sci Med Sci (2011) 1.72
Structure and mechanism of peptide methionine sulfoxide reductase, an "anti-oxidation" enzyme. Biochemistry (2000) 1.72
Molecular mechanisms of Spemann's organizer formation: conserved growth factor synergy between Xenopus and mouse. Genes Dev (1995) 1.71
The epidemiology of total knee replacement in South Korea: national registry data. Rheumatology (Oxford) (2008) 1.71
A new atmospherically relevant oxidant of sulphur dioxide. Nature (2012) 1.71
Studies on the enzymatic synthesis of the cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine in Escherichia coli. Biochemistry (1972) 1.70
Protein methylation: chemical, enzymological, and biological significance. Adv Enzymol Relat Areas Mol Biol (1975) 1.68
The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem (2001) 1.67
Silicone oil adhesion to intraocular lenses: an experimental study comparing various biomaterials. J Cataract Refract Surg (1997) 1.67